Onconetix, Inc. Files 8-K with Regulatory Updates
Ticker: ONCO · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1782107
Sentiment: neutral
Topics: 8-K, regulatory-disclosure, financial-reporting
TL;DR
Onconetix (ONCO) filed an 8-K on 6/16/25 - check for updates.
AI Summary
Onconetix, Inc. filed an 8-K on June 16, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc., is incorporated in Delaware and headquartered in Cincinnati, Ohio.
Why It Matters
This filing provides important updates and disclosures for investors regarding Onconetix, Inc.'s regulatory compliance and financial reporting.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks.
Key Numbers
- 001-41294 — SEC File Number (Identifies the company's filing with the SEC.)
- 83-2262816 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Onconetix, Inc. (company) — Registrant
- Blue Water Biotech, Inc. (company) — Former company name
- Blue Water Vaccines Inc. (company) — Former company name
- June 16, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Cincinnati, Ohio (location) — Principal executive offices
FAQ
What specific information is being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in this excerpt.
What financial statements and exhibits are included with this filing?
The filing states that Financial Statements and Exhibits are included, but the content of these documents is not detailed in the provided text.
When did Onconetix, Inc. change its name from Blue Water Biotech, Inc.?
The date of the name change from Blue Water Biotech, Inc. to Onconetix, Inc. was April 24, 2023.
What is the company's fiscal year end?
The company's fiscal year ends on December 31st.
What is the company's principal executive office address?
The principal executive offices are located at 201 E. Fifth Street, Suite 1900, Cincinnati, Ohio 45202.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding Onconetix, Inc. (ONCO).